MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MTSR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Metsera (MTSR) Ownership - Who owns Metsera?

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.43B
P/E Ratio
N/A
Total Cash
530.92M
Projected Growth
N/A
Total Debt
1.06M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.04
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for MTSR
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Who owns Metsera? MTSR symbol Ownership - Tickeron.com